Targovax to present at forthcoming conference
Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target, primarily, treatment-resistant solid tumors, announces that members of its senior management will present a corporate overview at the following conference:Biotech and Money Inv€$tival Showcase in partnership with JefferiesDate: 18 November 2016Participants: Øystein Soug (CEO) and Magnus Jäderberg (CMO)Presentation time: 12:00 GMTVenue: The Waldorf Hilton Hotel, London, UK The presentation will be available to download at www.targovax.com